OCAST Cessation Study (OCAST)
|ClinicalTrials.gov Identifier: NCT01921439|
Recruitment Status : Completed
First Posted : August 13, 2013
Last Update Posted : April 11, 2017
|Condition or disease||Intervention/treatment|
|Tobacco Smoking Behavior Cigarette Smoking Behavior Second Hand Tobacco Smoke Tobacco Use Cessation||Behavioral: Personalized Feedback|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||152 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Matching Brief Smoking Interventions to Stage of Change|
|Study Start Date :||July 2013|
|Primary Completion Date :||December 2016|
|Study Completion Date :||December 2016|
Active Comparator: Feedback
Participants in this group will receive individualized feedback based on their stage of change. Feedback will include health effects of smoking, money spent per month and per year on cigarettes, time spent smoking compared with time spent doing other daily tasks, and how the participant compares to past study participants in average number of cigarettes per day used and level of addiction.
Behavioral: Personalized Feedback
Personalized feedback reflecting the participant's current level of nicotine addiction, money spent on cigarettes, time spent smoking, and health effects of smoking.
No Intervention: No Feedback- Treatment as Usual (TAU)
Participants will take the computer based survey, but will only receive a number to the Oklahoma Tobacco Helpline (Treatment-as-usual condition) instead of feedback.
- Self-Reported Readiness and Motivation to Quit Smoking [ Time Frame: Baseline, 1-month, 6-months, 12-months ]We will assess changes in self-reported readiness and motivation to quit smoking.
- Parent and Child Salivary Cotinine [ Time Frame: Baseline, 1-month, 6-months, and 12-months ]We will assess change in parent and child salivary cotinine throughout the course of the study.
- Change in self-reported cigarette use [ Time Frame: baseline, 1-month, 6-months, and 12-months ]We will assess changes in self-reported cigarette use throughout the study.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01921439
|United States, Oklahoma|
|Oklahoma Tobacco Research Center|
|Oklahoma City, Oklahoma, United States, 73104|
|Principal Investigator:||Stephen Gillaspy, Ph.D.||The University of Oklahoma Health Sciences Center|